Product Description
| Brand |
Beckman Coulter |
| Sample Type |
Serum/ Plasma |
| Pack Size |
6 x 50T |
| CAT No. |
33211 |
Application
|
Tumor Marker |
The
Beckman Coulter Access AFP [Alpha- Fetoprotein] (CLIA) is a high-quality
Chemiluminescent Immunoassay (CLIA) reagent developed for the
quantitative determination of Alpha-Fetoprotein (AFP) in human serum and plasma. This Access AFP CLIA reagent provides accurate, sensitive, and reproducible results to support the diagnosis, monitoring, and management of various liver diseases and certain cancers. AFP testing is widely utilized as a
tumor marker for
hepatocellular carcinoma (HCC),
germ cell tumors, and as an aid in evaluating liver disorders.
Advanced CLIA Technology for Accurate AFP DetectionUtilizing Chemiluminescence Immunoassay (CLIA), the BC Access AFP Analyzer provides highly sensitive and specific results for AFP measurement. This technology ensures that laboratories can rely on precise data, supporting efficient diagnosis and monitoring of various medical conditions. Its automatic operation enhances productivity, making lab workflows smoother and analyses more reliable.
Portable and User-Friendly DesignThe BC Access AFP Analyzer is engineered for portability, allowing easy relocation within laboratory environments. Its automatic operating type reduces the need for manual intervention, streamlining routine AFP testing. With its compact structure (not wall-mounted), the analyzer fits various laboratory configurations, making it a versatile choice for healthcare facilities.
Safe Storage and Operation for Long-Term UseFor optimal performance and longevity, the BC Access AFP Analyzer should be stored at temperatures between 2 and 10 degrees Celsius. Its design accommodates real-time operation, guaranteeing immediate and accurate results. Proper storage and handling ensure the analyzer delivers consistent, reliable functionality over extended periods.
FAQ's of BC Access AFP (CLIA):
Q: How does the BC Access AFP (CLIA) Analyzer work for determining AFP levels?
A: The analyzer utilizes Chemiluminescence Immunoassay (CLIA) technology to precisely measure Alpha-Fetoprotein (AFP) in samples. The automated system processes samples and produces accurate, real-time results with minimal manual intervention.
Q: What are the recommended storage conditions for the BC Access AFP (CLIA) Analyzer?
A: For best performance and durability, the analyzer should be stored at a temperature range of 2 to 10 degrees Celsius. This prevents malfunction and preserves the sensitive components used in CLIA technology.
Q: When should laboratories opt for the BC Access AFP (CLIA) Analyzer?
A: Laboratories should choose this analyzer when they require rapid, reliable AFP detection to assist in disease screening and monitoring. Its automatic operation and real-time results make it suitable for frequent use in medium- to high-volume settings.
Q: Where can the BC Access AFP (CLIA) Analyzer be used?
A: This CLIA analyzer is designed for laboratory use and can be placed on a benchtop due to its portable build. It is distributed across India and is suitable for hospitals, diagnostic centers, and clinical labs.
Q: What is the benefit of using a portable, automatic CLIA Analyzer for AFP testing?
A: The portability allows for flexible laboratory arrangement, while automatic operation minimizes human errors, increases testing throughput, and improves consistency in test results.
Q: What is the process for using the BC Access AFP (CLIA) Analyzer in AFP detection?
A: To use the analyzer, add the prepared sample to the device, ensure it's maintained at the required storage temperature, and initiate the automatic run. The analyzer processes and reports AFP levels in real time, optimizing laboratory workflow.